JP2018529731A5 - - Google Patents

Download PDF

Info

Publication number
JP2018529731A5
JP2018529731A5 JP2018516728A JP2018516728A JP2018529731A5 JP 2018529731 A5 JP2018529731 A5 JP 2018529731A5 JP 2018516728 A JP2018516728 A JP 2018516728A JP 2018516728 A JP2018516728 A JP 2018516728A JP 2018529731 A5 JP2018529731 A5 JP 2018529731A5
Authority
JP
Japan
Prior art keywords
oxy
amino
amine
dimethylpentyl
pyridin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018516728A
Other languages
English (en)
Japanese (ja)
Other versions
JP6864674B2 (ja
JP2018529731A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/054464 external-priority patent/WO2017059080A1/en
Publication of JP2018529731A publication Critical patent/JP2018529731A/ja
Publication of JP2018529731A5 publication Critical patent/JP2018529731A5/ja
Application granted granted Critical
Publication of JP6864674B2 publication Critical patent/JP6864674B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018516728A 2015-10-01 2016-09-29 ビアリールキナーゼ阻害剤 Active JP6864674B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN3169DE2015 2015-10-01
IN3169/DEL/2015 2015-10-01
PCT/US2016/054464 WO2017059080A1 (en) 2015-10-01 2016-09-29 Biaryl kinase inhibitors

Publications (3)

Publication Number Publication Date
JP2018529731A JP2018529731A (ja) 2018-10-11
JP2018529731A5 true JP2018529731A5 (enExample) 2019-11-07
JP6864674B2 JP6864674B2 (ja) 2021-04-28

Family

ID=57137279

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018516728A Active JP6864674B2 (ja) 2015-10-01 2016-09-29 ビアリールキナーゼ阻害剤

Country Status (7)

Country Link
US (1) US10246469B2 (enExample)
EP (1) EP3356330B1 (enExample)
JP (1) JP6864674B2 (enExample)
KR (1) KR102707968B1 (enExample)
CN (1) CN108290843B (enExample)
ES (1) ES2767776T3 (enExample)
WO (1) WO2017059080A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102379518B1 (ko) 2014-04-02 2022-03-25 브리스톨-마이어스 스큅 컴퍼니 비아릴 키나제 억제제
WO2017059085A1 (en) 2015-10-01 2017-04-06 Bristol-Myers Squibb Company Biaryl kinase inhibitors
US10246469B2 (en) 2015-10-01 2019-04-02 Bristol-Myers Squibb Company Biaryl kinase inhibitors
SG11202104229WA (en) 2018-10-30 2021-05-28 Kronos Bio Inc Compounds, compositions, and methods for modulating cdk9 activity
JP7747523B2 (ja) * 2019-05-15 2025-10-01 バイオジェン・エムエイ・インコーポレイテッド ブルトン型チロシンキナーゼの阻害剤
CN117715899A (zh) * 2021-07-15 2024-03-15 西藏海思科制药有限公司 Aak1抑制剂及其用途
CN115872927A (zh) * 2021-09-30 2023-03-31 武汉人福创新药物研发中心有限公司 Aak1抑制剂及其用途
US20230330074A1 (en) * 2022-04-15 2023-10-19 Lexicon Pharmaceuticals, Inc. Compounds and methods for treating spasticity
CN115894353B (zh) * 2022-10-18 2025-08-29 山西永津集团有限公司 一种2,3-二氨基-4-溴吡啶的合成方法
CN120202001A (zh) * 2022-11-10 2025-06-24 西藏海思科制药有限公司 一种含aak1抑制剂的药物组合物
CN120344529A (zh) * 2022-12-13 2025-07-18 上海海雁医药科技有限公司 杂环取代的五并六元杂芳基衍生物、其药物组合物及应用与制备方法
WO2024153067A1 (zh) * 2023-01-16 2024-07-25 上海海雁医药科技有限公司 杂环取代的含氮杂环衍生物、其药物组合物及应用与制备方法
WO2024207945A1 (zh) * 2023-04-07 2024-10-10 艾立康药业股份有限公司 作为aak1抑制剂的氮杂环类化合物
CN118772152A (zh) * 2023-04-07 2024-10-15 艾立康药业股份有限公司 作为aak1抑制剂的氮杂环类化合物
CN116396241A (zh) * 2023-04-12 2023-07-07 南京优氟医药科技有限公司 一种叔丁基(r)-4-乙基-2,2-二氧化物-1,2,3-氧杂噻唑烷-3-羧酸的制备方法
WO2025092928A1 (zh) * 2023-11-02 2025-05-08 西藏海思科制药有限公司 一种可抑制连接蛋白相关激酶1的化合物、制备及其用途
WO2025225608A1 (en) * 2024-04-23 2025-10-30 Otsuka Pharmaceutical Co., Ltd. Tetrahydropyrazolopyridine derivative

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464764A (en) 1989-08-22 1995-11-07 University Of Utah Research Foundation Positive-negative selection methods and vectors
AU2515992A (en) 1991-08-20 1993-03-16 Genpharm International, Inc. Gene targeting in animal cells using isogenic dna constructs
AU2003286895A1 (en) 2002-11-05 2004-06-07 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of jak and other protein kinases
MX2008013203A (es) * 2006-04-12 2008-10-22 Wyeth Corp Analogos de anilino-pirimidina fenilo y benzotiofeno.
KR101641596B1 (ko) 2007-11-15 2016-07-21 엠에스디 이탈리아 에스.알.엘. Parp 억제제로서의 피리다지논 유도체
CN106359439B (zh) * 2012-02-29 2018-10-30 明治制果药业株式会社 包括新型亚氨基吡啶衍生物的有害物防治组合物
US8703953B2 (en) 2012-03-09 2014-04-22 Bristol-Myers Squibb Company Aryl ether-base kinase inhibitors
HUE036040T2 (hu) 2012-03-09 2018-06-28 Lexicon Pharmaceuticals Inc Adaptor-asszociált kináz 1 gátlása fájdalom kezelésére
US8901305B2 (en) * 2012-07-31 2014-12-02 Bristol-Myers Squibb Company Aryl lactam kinase inhibitors
US9708337B2 (en) 2013-02-22 2017-07-18 Bristol-Myers Squibb Company Aryl amide-based kinase inhibitors
EP3019475A1 (en) 2013-07-08 2016-05-18 Bristol-Myers Squibb Company Aryl amide kinase inhibitors
EP3044226B1 (en) 2013-09-11 2017-09-06 Bristol-Myers Squibb Company Aryl ether-base kinase inhibitors
KR20160058863A (ko) * 2013-09-19 2016-05-25 바스프 에스이 N-아실이미노 헤테로시클릭 화합물
CA2937529A1 (en) 2014-01-29 2015-08-06 Bristol-Myers Squibb Company Aryl lactam kinase inhibitors
MX2016009352A (es) 2014-01-31 2016-10-13 Bristol Myers Squibb Co Inhibidores de quinasa a base de quinolina.
KR102379518B1 (ko) * 2014-04-02 2022-03-25 브리스톨-마이어스 스큅 컴퍼니 비아릴 키나제 억제제
US20170239249A1 (en) 2014-09-30 2017-08-24 Bristol-Myers Squibb Company Quinazoline-based kinase inhibitors
WO2016164295A2 (en) 2015-04-10 2016-10-13 Bristol-Myers Squibb Company Fused pyridines as kinase inhibitors
US10246469B2 (en) 2015-10-01 2019-04-02 Bristol-Myers Squibb Company Biaryl kinase inhibitors
WO2017059085A1 (en) 2015-10-01 2017-04-06 Bristol-Myers Squibb Company Biaryl kinase inhibitors

Similar Documents

Publication Publication Date Title
JP2018529731A5 (enExample)
RU2473549C2 (ru) Пиримидиновые соединения, композиции и способы применения
RU2412943C2 (ru) ПРОИЗВОДНЫЕ АЦЕТИЛЕНИЛ-ПИРАЗОЛО-ПИРИМИДИНА В КАЧЕСТВЕ АНТАГОНИСТОВ mGluR2
KR101110530B1 (ko) 증식성 질환의 치료에 유용한 키나제 억제제
KR102021159B1 (ko) 트리시클릭 헤테로시클릭 화합물 및 jak 저해제
RU2424242C2 (ru) Азолопиримидины в качестве ингибиторов активности каннабиноидного рецептора 1
JP2020504136A5 (enExample)
JP7654071B2 (ja) 複素環スピロ化合物及び使用方法
JP2016537384A5 (enExample)
JP2001097889A (ja) Crfアンタゴニストおよび関連組成物の使用
US20180282282A1 (en) Isoquinolines as inhibitors of hpk1
JP2016500671A5 (enExample)
JP2007522200A5 (enExample)
RU2016140338A (ru) Азаспиро производные в качестве антагонистов trpm8
JP2013522354A5 (enExample)
HRP20120105T1 (hr) Aminoheterociklički spojevi
JP2016520116A5 (enExample)
JP2015508075A5 (enExample)
JP2017535561A5 (enExample)
RU2017121278A (ru) Триазоло-пиразинильные производные, применимые в качестве растворимых активаторов гуанилатциклазы
JP2005500315A5 (enExample)
JP2019536768A5 (enExample)
RU2007119449A (ru) Соединения и композиции в качестве ингибиторов активности каннабиноидного рецептора 1
RU2006130003A (ru) Применение производных пиразоло[1, 5-а]пиримидин-7-иламина для лечения заболеваний, зависимых от протеинкиназ
WO2022093856A1 (en) Heterocyclic spiro compounds and methods of use